We are live on ! Find out more
ACM

Accipiter Capital Management Portfolio holdings

AUM $124M
1-Year Est. Return 6.47%
This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
-6.47%
3 Year Est. Return
-55.92%
5 Year Est. Return
10 Year Est. Return
AUM
$308M
AUM Growth
+$260M
Cap. Flow
+$229M
Cap. Flow %
74.28%
Top 10 Hldgs %
100%
Holding
9
New
5
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$6.65M
2
CVS icon
CVS Health
CVS
+$6.59M
3
WBA
Walgreens Boots Alliance
WBA
+$6.44M
4
CI icon
Cigna
CI
+$2.6M
5
SCI icon
Service Corp International
SCI
+$926K

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$12M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$970K

Sector Composition

Rank Sector Weight
1 Energy 10.26%
2 Healthcare 7.59%
3 Communication Services 2.09%
4 Consumer Discretionary 0.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
1
PUT
Tesla
TSLA
$1.18T
$246M 79.77%
+10,740,000
New +$218M
FELP
2
DELISTED
Foresight Energy LP
FELP
$31.6M 10.26%
7,705,398
+40,475
+0.5% +$150K
CI icon
3
Cigna
CI
$78.4B
$8.5M 2.76%
50,000
+15,000
+43% +$2.6M
CVS icon
4
CVS Health
CVS
$135B
$6.43M 2.09%
+100,000
New +$6.59M
T icon
5
AT&T
T
$164B
$6.42M 2.09%
+264,800
New +$6.65M
WBA
6
DELISTED
Walgreens Boots Alliance
WBA
$6M 1.95%
+100,000
New +$6.44M
TEVA icon
7
Teva Pharmaceuticals
TEVA
$40.4B
$2.43M 0.79%
100,000
-47,571
-32% -$970K
SCI icon
8
Service Corp International
SCI
$11.8B
$895K 0.29%
+25,000
New +$926K
SHPG
9
DELISTED
Shire pic
SHPG
-80,270
Closed -$12M

Similar funds

Accipiter Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Accipiter Capital Management held 9 positions worth $308M, up 550% from $47.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Accipiter Capital Management deployed $229M of net new capital in Q2 2018, opening 5 new positions and adding to 2 existing holdings. Its largest new stake was AT&T: 264,800 shares worth $6.42M.

By sector, the portfolio is most concentrated in Energy at 10% of assets, down from 57% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $970K trimmed.

  • Accipiter Capital Management's largest Q2 2018 buy was AT&T: 264,800 shares worth $6.42M.
  • Accipiter Capital Management added most to Cigna in Q2 2018, an estimated $2.6M increase.
  • Accipiter Capital Management's biggest Q2 2018 reduction was Teva Pharmaceuticals, cutting an estimated $970K.
  • Accipiter Capital Management fully exited Shire pic in Q2 2018, selling an estimated $12M.
  • Accipiter Capital Management's ten largest holdings make up 100% of its $308M portfolio in Q2 2018.
  • Accipiter Capital Management opened 5 new positions and closed 1 in Q2 2018.
  • Accipiter Capital Management's portfolio value rose 550% quarter-over-quarter to $308M.

Based on Accipiter Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.